Lubio Science Webinar: PARP inhibition restores MAPK inhibitor sensitivity in melanoma 05.05.22 16:00-17:00
Date and Time: Thursday, May 5th at 16:00 CET – 17:00 CET
Webinar title: PARP inhibition restores MAPK inhibitor sensitivity in melanoma
“Cutaneous malignant melanoma is the most aggressive type of skin cancer and is responsible for approximately 75% of all skin tumor deaths. Inhibitors of the MAPK signaling pathway (MAPKi) have become important therapies to combat this disease, though resistance to these agents limits their long-term benefit. Understanding how MAPKi resistance arises will offer insight into how to defeat it.
Dr. Lorenza Ferretti’s work focuses on the discovery and characterization of epigenetic alterations responsible for MAPKi resistance. In this webinar, Dr. Ferretti will present her 3D drug screening approach in patient-derived melanoma cells and her compelling findings that PARP inhibition dramatically enhances the efficacy of MAPK inhibitors in cells previously resistant to these agents.”
Registration link: https://teams.microsoft.com/registration/O7M-aacqZku0ALhMP4BtHQ,Z_h-yAcCb0OvJbWobnbABg,wtK_vKUVZkSuGYSOJAmZCw,7_s13DaGh0qYiYRS5XQOBQ,kSPXOG0PW0yOGWVsHxtlrQ,wbaxA24DZEyW_T-IGN8sig?mode=read&tenantId=693eb33b-2aa7-4b66-b400-b84c3f806d1d
Link to event on our website: https://www.lubio.ch/events/event/parp-inhibition-restores-mapk-inhibitor-sensitivity-in-melanoma